IONS vs POST
Ionis Pharmaceuticals Inc (IONS) versus Post Holdings Inc (POST) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
IONS currently screens at market cap $12.28B. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Not investment advice. Open the IONS and POST stock pages for the full models.
Not investment advice.